Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu,Cancer Genome Atlas Research Network,Adrian Ally,Miruna Balasundaram,Rebecca Carlsen,Eric Chuah,Amanda Clarke,Noreen Dhalla,Robert A Holt,Steven J M Jones,Darlene Lee,Yussanne Ma,Marco A Marra,Michael Mayo,Richard A Moore,Andrew J Mungall,Jacqueline E Schein,Payal Sipahimalani,Angela Tam,Nina Thiessen,Dorothy Cheung,Tina Wong,Denise Brooks,A Gordon Robertson,Reanne Bowlby,Karen Mungall,Sara Sadeghi,Liu Xi,Kyle Covington,Eve Shinbrot,David A Wheeler,Richard A Gibbs,Lawrence A Donehower,Linghua Wang,Jay Bowen,Julie M Gastier-Foster,Mark Gerken,Carmen Helsel,Kristen M Leraas,Tara M Lichtenberg,Nilsa C Ramirez,Lisa Wise,Erik Zmuda,Stacey B Gabriel,Matthew Meyerson,Carrie Cibulskis,Bradley A Murray,Juliann Shih,Rameen Beroukhim,Andrew D Cherniack,Steven E Schumacher,Gordon Saksena,Chandra Sekhar Pedamallu,Lynda Chin,Gad Getz,Michael Noble,Hailei Zhang,David Heiman,Juok Cho,Nils Gehlenborg,Douglas Voet,Pei Lin,Scott Frazer,Timothy Defreitas,Sam Meier,Michael Lawrence,Jaegil Kim,Chad J Creighton,Donna Muzny,HarshaVardhan Doddapaneni,Jianhong Hu,Min Wang,Donna Morton,Viktoriya Korchina,Yi Han,Huyen Dinh,Lora Lewis,Michelle Bellair,Xiuping Liu,Jireh Santibanez,Robert Glenn,Sandra Lee,Walker Hale,Joel S Parker,Matthew D Wilkerson,D Neil Hayes,Sheila M Reynolds,Ilya Shmulevich,Wei Zhang,Yuexin Liu,Lisa Iype,Hala Makhlouf,Michael S Torbenson,Sanjay Kakar,Matthew M Yeh,Dhanpat Jain,David E Kleiner,Renumathy Dhanasekaran,Hashem B El-Serag,Sun Young Yim,John N Weinstein,Lopa Mishra,Jianping Zhang,Rehan Akbani,Shiyun Ling,Zhenlin Ju,Xiaoping Su,Apurva M Hegde,Gordon B Mills,Yiling Lu,Jian Chen,Ju-Seog Lee,Bo Hwa Sohn,Jae Jun Shim,Pan Tong,Hiroyuki Aburatani,Shogo Yamamoto,Kenji Tatsuno,Wei Li,Zheng Xia,Nicolas Stransky,Eric Seiser,Federico Innocenti,Jianjiong Gao,Ritika Kundra,Hongxin Zhang,Zachary Heins,Angelica Ochoa,Chris Sander,Marc Ladanyi,Ronglai Shen,Arshi Arora,Francisco Sanchez-Vega,Nikolaus Schultz,Katayoon Kasaian,Amie Radenbaugh,Karl-Dimiter Bissig,David D Moore,Yasushi Totoki,Hiromi Nakamura,Tatsuhiro Shibata,Christina Yau,Kiley Graim,Josh Stuart,David Haussler,Betty L Slagle,Akinyemi I Ojesina,Panagiotis Katsonis,Amanda Koire,Olivier Lichtarge,Teng-Kuei Hsu,Martin L Ferguson,John A Demchok,Ina Felau,Margi Sheth,Roy Tarnuzzer,Zhining Wang,Liming Yang,Jean C Zenklusen,Jiashan Zhang,Carolyn M Hutter,Heidi J Sofia,Roel G W Verhaak,Siyuan Zheng,Frederick Lang,Sudha Chudamani,Jia Liu,Laxmi Lolla,Ye Wu,Rashi Naresh,Todd Pihl,Charlie Sun,Yunhu Wan,Christopher Benz,Amy H Perou,Leigh B Thorne,Lori Boice,Mei Huang,W Kimryn Rathmell,Houtan Noushmehr,Fabiano Pinto Saggioro,Daniela Pretti da Cunha Tirapelli,Carlos Gilberto Carlotti Junior,Enio David Mente,Orlando de Castro Silva Jr,Felipe Amstalden Trevisan,Koo Jeong Kang,Keun Soo Ahn,Nasra H Giama,Catherine D Moser,Thomas J Giordano,Michelle Vinco,Theodore H Welling,Daniel Crain,Erin Curley,Johanna Gardner,David Mallery,Scott Morris,Joseph Paulauskis,Robert Penny,Candace Shelton,Troy Shelton,Robin Kelley,Joong-Won Park,Vishal S Chandan,Lewis R Roberts,Oliver F Bathe,Curt H Hagedorn,J Todd Auman,Daniel R O'Brien,Jean-Pierre A Kocher,Corbin D Jones,Piotr A Mieczkowski,Charles M Perou,Tara Skelly,Donghui Tan,Umadevi Veluvolu,Saianand Balu,Tom Bodenheimer,Alan P Hoyle,Stuart R Jefferys,Shaowu Meng,Lisle E Mose,Yan Shi,Janae V Simons,Matthew G Soloway,Jeffrey Roach,Katherine A Hoadley,Stephen B Baylin,Hui Shen,Toshinori Hinoue,Moiz S Bootwalla,David J Van Den Berg,Daniel J Weisenberger,Phillip H Lai,Andrea Holbrook,Mario Berrios,Peter W Laird

Abstract:Liver cancer has the second highest worldwide cancer mortality rate and has limited therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome sequencing and DNA copy number analyses, and we analyzed 196 HCC cases by DNA methylation, RNA, miRNA, and proteomic expression also. DNA sequencing and mutation analysis identified significantly mutated genes, including LZTR1, EEF1A1, SF3B1, and SMARCA4. Significant alterations by mutation or downregulation by hypermethylation in genes likely to result in HCC metabolic reprogramming (ALB, APOB, and CPS1) were observed. Integrative molecular HCC subtyping incorporating unsupervised clustering of five data platforms identified three subtypes, one of which was associated with poorer prognosis in three HCC cohorts. Integrated analyses enabled development of a p53 target gene expression signature correlating with poor survival. Potential therapeutic targets for which inhibitors exist include WNT signaling, MDM4, MET, VEGFA, MCL1, IDH1, TERT, and immune checkpoint proteins CTLA-4, PD-1, and PD-L1.

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma